Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Downgrade
Benchmark says Invitae 'ahead of itself,' downgrades to Hold after run-up » 06:40
07/01/20
07/01
06:40
07/01/20
06:40
NVTA

Invitae

$30.36 /

+2.2 (+7.81%)

As previously reported,…

As previously reported, Benchmark analyst Bruce Jackson downgraded Invitae to Hold from Buy following the run-up in the stock that has come since the company announced its "transformative" deal to acquire privately-held ArcherDX. While he sees the combination as a long-term strategic positive for the company, Jackson thinks the stock has gotten "ahead of itself," he tells investors. Jackson estimates a valuation range of $26 to $32 per share for the combined entity, he noted.

ShowHide Related Items >><<
NVTA Invitae
$30.36 /

+2.2 (+7.81%)

NVTA Invitae
$30.36 /

+2.2 (+7.81%)

07/01/20 Benchmark
Invitae downgraded to Hold from Buy at Benchmark
06/26/20 Cowen
Invitae price target raised to $35 from $18 at Cowen
06/22/20 Piper Sandler
Invitae deal for ArcherDx presents little threat to Natera, says Piper Sandler
05/06/20 SVB Leerink
Invitae price target raised to $25 from $20 at SVB Leerink
NVTA Invitae
$30.36 /

+2.2 (+7.81%)

  • 02
    Apr
NVTA Invitae
$30.36 /

+2.2 (+7.81%)

NVTA Invitae
$30.36 /

+2.2 (+7.81%)

Downgrade
Invitae downgraded to Hold from Buy at Benchmark » 06:16
07/01/20
07/01
06:16
07/01/20
06:16
NVTA

Invitae

$30.36 /

+2.2 (+7.81%)

Benchmark analyst Bruce…

Benchmark analyst Bruce Jackson downgraded Invitae to Hold from Buy.

ShowHide Related Items >><<
NVTA Invitae
$30.36 /

+2.2 (+7.81%)

NVTA Invitae
$30.36 /

+2.2 (+7.81%)

06/26/20 Cowen
Invitae price target raised to $35 from $18 at Cowen
06/22/20 Piper Sandler
Invitae deal for ArcherDx presents little threat to Natera, says Piper Sandler
05/06/20 SVB Leerink
Invitae price target raised to $25 from $20 at SVB Leerink
04/02/20 Oppenheimer
Invitae price target lowered to $25 from $32 at Oppenheimer
NVTA Invitae
$30.36 /

+2.2 (+7.81%)

  • 02
    Apr
NVTA Invitae
$30.36 /

+2.2 (+7.81%)

NVTA Invitae
$30.36 /

+2.2 (+7.81%)

Over a week ago
Recommendations
Invitae price target raised to $35 from $18 at Cowen » 08:34
06/26/20
06/26
08:34
06/26/20
08:34
NVTA

Invitae

$27.97 /

+0.495 (+1.80%)

Cowen analyst Doug…

Cowen analyst Doug Schenkel raised the firm's price target on Invitae to $35 from $18 and keeps an Outperform rating on the shares. The analyst believes its multiple should increase following its transformative acquisition of ArcherDx which provides it with an unmatched menu of products, and adds the real and likely possibility of unmodeled revenue upside in 2021.

ShowHide Related Items >><<
NVTA Invitae
$27.97 /

+0.495 (+1.80%)

NVTA Invitae
$27.97 /

+0.495 (+1.80%)

06/22/20 Piper Sandler
Invitae deal for ArcherDx presents little threat to Natera, says Piper Sandler
05/06/20 SVB Leerink
Invitae price target raised to $25 from $20 at SVB Leerink
04/02/20 Oppenheimer
Invitae price target lowered to $25 from $32 at Oppenheimer
02/20/20 Cowen
Invitae price target raised to $30 from $20 at Cowen
NVTA Invitae
$27.97 /

+0.495 (+1.80%)

  • 02
    Apr
NVTA Invitae
$27.97 /

+0.495 (+1.80%)

NVTA Invitae
$27.97 /

+0.495 (+1.80%)

Options
Invitae call volume above normal and directionally bullish » 14:25
06/25/20
06/25
14:25
06/25/20
14:25
NVTA

Invitae

$27.66 /

+0.185 (+0.67%)

Bullish option flow…

Bullish option flow detected in Invitae with 4,976 calls trading, 1.2x expected, and implied vol increasing over 1 point to 87.46%. Jul-20 30 calls and Jul-20 35 calls are the most active options, with total volume in those strikes near 2,500 contracts. The Put/Call Ratio is 0.34. Earnings are expected on August 4th.

ShowHide Related Items >><<
NVTA Invitae
$27.66 /

+0.185 (+0.67%)

NVTA Invitae
$27.66 /

+0.185 (+0.67%)

06/22/20 Piper Sandler
Invitae deal for ArcherDx presents little threat to Natera, says Piper Sandler
05/06/20 SVB Leerink
Invitae price target raised to $25 from $20 at SVB Leerink
04/02/20 Oppenheimer
Invitae price target lowered to $25 from $32 at Oppenheimer
02/20/20 Cowen
Invitae price target raised to $30 from $20 at Cowen
NVTA Invitae
$27.66 /

+0.185 (+0.67%)

NVTA Invitae
$27.66 /

+0.185 (+0.67%)

NVTA Invitae
$27.66 /

+0.185 (+0.67%)

Hot Stocks
BridgeBio appoints Brent Saunders, Randy Scott, Andrew Lo to board » 07:44
06/24/20
06/24
07:44
06/24/20
07:44
BBIO

BridgeBio

$32.63 /

-0.44 (-1.33%)

, NVTA

Invitae

$30.01 /

+3.02 (+11.19%)

BridgeBio Pharma (BBIO)…

BridgeBio Pharma (BBIO) has added three new independent directors to its board: Brent Saunders, Randy Scott, Ph.D. and Andrew Lo, Ph.D. Saunders most recently served as chairman, president and CEO of Allergan. Scott recently served as CEO and executive chairman at Invitae (NVTA), a company he co-founded to bring genetic information into routine medical practice. Lo is the Charles E. and Susan T. Harris Professor at the MIT Sloan School of Management, director of the MIT Laboratory for Financial Engineering, a principal investigator at the MIT Computer Science and Artificial Intelligence Laboratory, and an affiliated faculty member of the MIT Department of Electrical Engineering and Computer Science.

ShowHide Related Items >><<
NVTA Invitae
$30.01 /

+3.02 (+11.19%)

BBIO BridgeBio
$32.63 /

-0.44 (-1.33%)

BBIO BridgeBio
$32.63 /

-0.44 (-1.33%)

06/05/20 Mizuho
HFA slide 'good' for BridgeBio, Eidos' AG10, says Mizuho
05/29/20 Piper Sandler
Piper Sandler 'encouraged' by BridgeBio data presented at ASCO
05/19/20 BTIG
BridgeBio initiated with a Buy at BTIG
05/11/20 Piper Sandler
Piper Sandler says BridgeBio's Infigratinib 'attractive candidate' for ACH
NVTA Invitae
$30.01 /

+3.02 (+11.19%)

06/22/20 Piper Sandler
Invitae deal for ArcherDx presents little threat to Natera, says Piper Sandler
05/06/20 SVB Leerink
Invitae price target raised to $25 from $20 at SVB Leerink
04/02/20 Oppenheimer
Invitae price target lowered to $25 from $32 at Oppenheimer
02/20/20 Cowen
Invitae price target raised to $30 from $20 at Cowen
NVTA Invitae
$30.01 /

+3.02 (+11.19%)

BBIO BridgeBio
$32.63 /

-0.44 (-1.33%)

NVTA Invitae
$30.01 /

+3.02 (+11.19%)

NVTA Invitae
$30.01 /

+3.02 (+11.19%)

BBIO BridgeBio
$32.63 /

-0.44 (-1.33%)

Hot Stocks
Qiagen sees pre-tax capital gain of $120M on ArcherDX minority investment » 13:54
06/23/20
06/23
13:54
06/23/20
13:54
QGEN

Qiagen

$42.91 /

+0.35 (+0.82%)

, NVTA

Invitae

$29.73 /

+2.74 (+10.15%)

Qiagen (QGEN) announces…

Qiagen (QGEN) announces that according to the intended business combination between Invitae (NVTA) and ArcherDX, Qiagen could realize a significant pre-tax capital gain from its minority investment in ArcherDX. As of June 23, Qiagen held an equity stake on a fully diluted basis in ArcherDX of approximately 8%. The current book value of Qiagen's shareholding in ArcherDX is $20M. Under the terms of the combination agreement as disclosed publicly, Invitae will acquire ArcherDX for upfront consideration consisting of 30M shares of Invitae common stock and $325M in cash, plus up to an additional 27M shares of Invitae common stock payable in connection with the achievement of certain milestones. The consideration is subject to customary purchase-price adjustments. Based on the closing share price of Invitae on the New York Stock Exchange of $27.05 on June 22, and assuming a full payout of the contingent consideration and further preliminary information taken into account, Qiagen estimates that its pre-tax capital gain could be approximately $120M. Qiagen has held the investment in ArcherDX since 2015, when it acquired the enzymes solutions unit of Enzymatics, a U.S.-based supplier of enzymes used in next-generation sequencing and other genetic analysis technologies.

ShowHide Related Items >><<
QGEN Qiagen
$42.91 /

+0.35 (+0.82%)

NVTA Invitae
$29.73 /

+2.74 (+10.15%)

QGEN Qiagen
$42.91 /

+0.35 (+0.82%)

03/04/20 Stifel
Qiagen deal a positive for Thermo Fisher, says Stifel
03/04/20 Berenberg
Qiagen downgraded to Hold from Buy at Berenberg
03/03/20 Piper Sandler
Danaher unlikely to make competing bid for Qiagen, says Piper Sandler
02/05/20 Piper Sandler
Qiagen price target raised to $36 from $29 at Piper Sandler
NVTA Invitae
$29.73 /

+2.74 (+10.15%)

06/22/20 Piper Sandler
Invitae deal for ArcherDx presents little threat to Natera, says Piper Sandler
05/06/20 SVB Leerink
Invitae price target raised to $25 from $20 at SVB Leerink
04/02/20 Oppenheimer
Invitae price target lowered to $25 from $32 at Oppenheimer
02/20/20 Cowen
Invitae price target raised to $30 from $20 at Cowen
QGEN Qiagen
$42.91 /

+0.35 (+0.82%)

NVTA Invitae
$29.73 /

+2.74 (+10.15%)

QGEN Qiagen
$42.91 /

+0.35 (+0.82%)

QGEN Qiagen
$42.91 /

+0.35 (+0.82%)

NVTA Invitae
$29.73 /

+2.74 (+10.15%)

QGEN Qiagen
$42.91 /

+0.35 (+0.82%)

NVTA Invitae
$29.73 /

+2.74 (+10.15%)

On The Fly
Fly Intel: Wall Street's top stories for Monday » 16:23
06/22/20
06/22
16:23
06/22/20
16:23
AAPL

Apple

$358.71 /

+9.16 (+2.62%)

, INTC

Intel

$60.10 /

+0.51 (+0.86%)

, TSN

Tyson Foods

$61.40 /

-1.83 (-2.89%)

, PEP

PepsiCo

$131.04 /

-0.23 (-0.18%)

, SPCE

Virgin Galactic

$17.38 /

+2.4 (+16.02%)

, GILD

Gilead

$75.62 /

-1.61 (-2.08%)

, IDEX

Ideanomics

$3.28 /

+1.06 (+47.75%)

, NVTA

Invitae

$27.01 /

+8.4 (+45.14%)

, LTHM

Livent

$6.44 /

-1.22 (-15.93%)

, LK

Luckin Coffee

$3.20 /

-0.645 (-16.78%)

Stocks continue to…

Open Full Text

ShowHide Related Items >><<
TSN Tyson Foods
$61.40 /

-1.83 (-2.89%)

SPCE Virgin Galactic
$17.38 /

+2.4 (+16.02%)

PEP PepsiCo
$131.04 /

-0.23 (-0.18%)

NVTA Invitae
$27.01 /

+8.4 (+45.14%)

LTHM Livent
$6.44 /

-1.22 (-15.93%)

LK Luckin Coffee
$3.20 /

-0.645 (-16.78%)

INTC Intel
$60.10 /

+0.51 (+0.86%)

IDEX Ideanomics
$3.28 /

+1.06 (+47.75%)

GILD Gilead
$75.62 /

-1.61 (-2.08%)

AAPL Apple
$358.71 /

+9.16 (+2.62%)

AAPL Apple
$358.71 /

+9.16 (+2.62%)

06/23/20 Deutsche Bank
Intel loss of Mac business 'clearly negative', says Deutsche Bank
06/23/20 Deutsche Bank
Apple price target raised to $380 from $350 at Deutsche Bank
06/23/20 Bernstein
Apple price target raised to $370 from $285 at Bernstein
INTC Intel
$60.10 /

+0.51 (+0.86%)

06/23/20 Citi
Apple unlikely to move completely away from Intel, says Citi
06/22/20 Cowen
Apple price target raised to $400 from $335 at Cowen
TSN Tyson Foods
$61.40 /

-1.83 (-2.89%)

06/10/20 Credit Suisse
Tyson Foods price target raised to $75 from $70 at Credit Suisse
06/04/20
Fly Intel: Top five analyst upgrades
06/04/20 BofA
BofA cuts Pilgrim's Pride, Sanderson Farms targets after price fixing indictment
06/04/20 Bernstein
Tyson Foods upgraded to Outperform with $83 target at Bernstein
PEP PepsiCo
$131.04 /

-0.23 (-0.18%)

06/17/20 Jefferies
Nestle home-office water business would be a fit for Primo Water, says Jefferies
06/01/20 Goldman Sachs
Monster Beverage price target raised to $78 from $70 at Goldman Sachs
05/18/20 Guggenheim
Guggenheim raises PepsiCo to 'Best Idea' in Food and Beverage, ups target
05/05/20 Guggenheim
Guggenheim sees 'strong case' for Coca-Cola to increase Monster ownership
SPCE Virgin Galactic
$17.38 /

+2.4 (+16.02%)

03/24/20 Morgan Stanley
Morgan Stanley upgrades Virgin Galactic to Overweight after over 70% drop
03/24/20 Morgan Stanley
Virgin Galactic upgraded to Overweight from Equal Weight at Morgan Stanley
03/03/20 Morgan Stanley
Lead up to next lunar landings can have 'powerful impact,' says Morgan Stanley
02/27/20
Fly Intel: Top five analyst downgrades
GILD Gilead
$75.62 /

-1.61 (-2.08%)

06/10/20 SunTrust
Arcus Biosciences price target raised to $45 from $22 at SunTrust
06/08/20 SVB Leerink
Gilead unlikely to be responsive to AstraZeneca's outreach, says SVB Leerink
06/08/20 JPMorgan
JPMorgan's Kasimov gives 'GileastraZeneca' low odds of happening
06/08/20 Jefferies
Jefferies' Welford questions benefit to AstraZeneca of merger with Gilead
IDEX Ideanomics
$3.28 /

+1.06 (+47.75%)

NVTA Invitae
$27.01 /

+8.4 (+45.14%)

06/22/20 Piper Sandler
Invitae deal for ArcherDx presents little threat to Natera, says Piper Sandler
05/06/20 SVB Leerink
Invitae price target raised to $25 from $20 at SVB Leerink
04/02/20 Oppenheimer
Invitae price target lowered to $25 from $32 at Oppenheimer
02/20/20 Cowen
Invitae price target raised to $30 from $20 at Cowen
LTHM Livent
$6.44 /

-1.22 (-15.93%)

04/05/20 BMO Capital
Livent upgraded to Market Perform from Underperform at BMO Capital
03/30/20 Goldman Sachs
Livent downgraded to Neutral from Buy at Goldman Sachs
03/26/20 Vertical Research
Livent upgraded to Hold from Sell at Vertical Research
03/26/20 KeyBanc
KeyBanc initiates Livent with Sector Weight on lack of capex financing clarity
LK Luckin Coffee
$3.20 /

-0.645 (-16.78%)

04/08/20 GLJ Research
JinkoSolar price target lowered to $6.88 from $7.97 at GLJ Research
04/08/20 UBS
Starbucks price target lowered to $73 from $95 at UBS
04/06/20 MKM Partners
Starbucks price target raised to $60 from $52 at MKM Partners
04/02/20 KeyBanc
KeyBanc cuts Luckin Coffee to Sector Weight as company probes fake transactions
TSN Tyson Foods
$61.40 /

-1.83 (-2.89%)

SPCE Virgin Galactic
$17.38 /

+2.4 (+16.02%)

PEP PepsiCo
$131.04 /

-0.23 (-0.18%)

NVTA Invitae
$27.01 /

+8.4 (+45.14%)

LTHM Livent
$6.44 /

-1.22 (-15.93%)

INTC Intel
$60.10 /

+0.51 (+0.86%)

GILD Gilead
$75.62 /

-1.61 (-2.08%)

AAPL Apple
$358.71 /

+9.16 (+2.62%)

TSN Tyson Foods
$61.40 /

-1.83 (-2.89%)

SPCE Virgin Galactic
$17.38 /

+2.4 (+16.02%)

PEP PepsiCo
$131.04 /

-0.23 (-0.18%)

LTHM Livent
$6.44 /

-1.22 (-15.93%)

LK Luckin Coffee
$3.20 /

-0.645 (-16.78%)

INTC Intel
$60.10 /

+0.51 (+0.86%)

GILD Gilead
$75.62 /

-1.61 (-2.08%)

AAPL Apple
$358.71 /

+9.16 (+2.62%)

TSN Tyson Foods
$61.40 /

-1.83 (-2.89%)

SPCE Virgin Galactic
$17.38 /

+2.4 (+16.02%)

PEP PepsiCo
$131.04 /

-0.23 (-0.18%)

NVTA Invitae
$27.01 /

+8.4 (+45.14%)

LTHM Livent
$6.44 /

-1.22 (-15.93%)

LK Luckin Coffee
$3.20 /

-0.645 (-16.78%)

INTC Intel
$60.10 /

+0.51 (+0.86%)

IDEX Ideanomics
$3.28 /

+1.06 (+47.75%)

GILD Gilead
$75.62 /

-1.61 (-2.08%)

AAPL Apple
$358.71 /

+9.16 (+2.62%)

TSN Tyson Foods
$61.40 /

-1.83 (-2.89%)

SPCE Virgin Galactic
$17.38 /

+2.4 (+16.02%)

PEP PepsiCo
$131.04 /

-0.23 (-0.18%)

NVTA Invitae
$27.01 /

+8.4 (+45.14%)

LK Luckin Coffee
$3.20 /

-0.645 (-16.78%)

INTC Intel
$60.10 /

+0.51 (+0.86%)

IDEX Ideanomics
$3.28 /

+1.06 (+47.75%)

GILD Gilead
$75.62 /

-1.61 (-2.08%)

AAPL Apple
$358.71 /

+9.16 (+2.62%)

INTC Intel
$60.10 /

+0.51 (+0.86%)

AAPL Apple
$358.71 /

+9.16 (+2.62%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:02
06/22/20
06/22
12:02
06/22/20
12:02
AAPL

Apple

$355.54 /

+5.99 (+1.71%)

, SPCE

Virgin Galactic

$16.82 /

+1.84 (+12.28%)

, TSN

Tyson Foods

$61.33 /

-1.9 (-3.00%)

, PEP

PepsiCo

$131.53 /

+0.26 (+0.20%)

, IDEX

Ideanomics

$3.82 /

+1.6 (+72.07%)

, NVTA

Invitae

$26.11 /

+7.5 (+40.30%)

, LTHM

Livent

$6.53 /

-1.135 (-14.82%)

, LK

Luckin Coffee

$3.19 /

-0.655 (-17.04%)

Stocks are higher at…

Open Full Text

ShowHide Related Items >><<
TSN Tyson Foods
$61.33 /

-1.9 (-3.00%)

SPCE Virgin Galactic
$16.82 /

+1.84 (+12.28%)

PEP PepsiCo
$131.53 /

+0.26 (+0.20%)

NVTA Invitae
$26.11 /

+7.5 (+40.30%)

LTHM Livent
$6.53 /

-1.135 (-14.82%)

LK Luckin Coffee
$3.19 /

-0.655 (-17.04%)

IDEX Ideanomics
$3.82 /

+1.6 (+72.07%)

AAPL Apple
$355.54 /

+5.99 (+1.71%)

AAPL Apple
$355.54 /

+5.99 (+1.71%)

06/22/20 Deutsche Bank
Apple store closures to have little impact on fundamentals, says Deutsche Bank
06/22/20 Cowen
Apple price target raised to $400 from $335 at Cowen
06/22/20 Barclays
Cirrus Logic downgraded to Underweight with $60 price target at Barclays
06/19/20 Jefferies
Apple price target raised to $405 from $370 at Jefferies
SPCE Virgin Galactic
$16.82 /

+1.84 (+12.28%)

03/24/20 Morgan Stanley
Morgan Stanley upgrades Virgin Galactic to Overweight after over 70% drop
03/24/20 Morgan Stanley
Virgin Galactic upgraded to Overweight from Equal Weight at Morgan Stanley
03/03/20 Morgan Stanley
Lead up to next lunar landings can have 'powerful impact,' says Morgan Stanley
02/27/20
Fly Intel: Top five analyst downgrades
TSN Tyson Foods
$61.33 /

-1.9 (-3.00%)

06/10/20 Credit Suisse
Tyson Foods price target raised to $75 from $70 at Credit Suisse
06/04/20
Fly Intel: Top five analyst upgrades
06/04/20 BofA
BofA cuts Pilgrim's Pride, Sanderson Farms targets after price fixing indictment
06/04/20 Bernstein
Tyson Foods upgraded to Outperform with $83 target at Bernstein
PEP PepsiCo
$131.53 /

+0.26 (+0.20%)

06/17/20 Jefferies
Nestle home-office water business would be a fit for Primo Water, says Jefferies
06/01/20 Goldman Sachs
Monster Beverage price target raised to $78 from $70 at Goldman Sachs
05/18/20 Guggenheim
Guggenheim raises PepsiCo to 'Best Idea' in Food and Beverage, ups target
05/05/20 Guggenheim
Guggenheim sees 'strong case' for Coca-Cola to increase Monster ownership
IDEX Ideanomics
$3.82 /

+1.6 (+72.07%)

NVTA Invitae
$26.11 /

+7.5 (+40.30%)

06/22/20 Piper Sandler
Invitae deal for ArcherDx presents little threat to Natera, says Piper Sandler
05/06/20 SVB Leerink
Invitae price target raised to $25 from $20 at SVB Leerink
04/02/20 Oppenheimer
Invitae price target lowered to $25 from $32 at Oppenheimer
02/20/20 Cowen
Invitae price target raised to $30 from $20 at Cowen
LTHM Livent
$6.53 /

-1.135 (-14.82%)

04/05/20 BMO Capital
Livent upgraded to Market Perform from Underperform at BMO Capital
03/30/20 Goldman Sachs
Livent downgraded to Neutral from Buy at Goldman Sachs
03/26/20 Vertical Research
Livent upgraded to Hold from Sell at Vertical Research
03/26/20 KeyBanc
KeyBanc initiates Livent with Sector Weight on lack of capex financing clarity
LK Luckin Coffee
$3.19 /

-0.655 (-17.04%)

04/08/20 GLJ Research
JinkoSolar price target lowered to $6.88 from $7.97 at GLJ Research
04/08/20 UBS
Starbucks price target lowered to $73 from $95 at UBS
04/06/20 MKM Partners
Starbucks price target raised to $60 from $52 at MKM Partners
04/02/20 KeyBanc
KeyBanc cuts Luckin Coffee to Sector Weight as company probes fake transactions
TSN Tyson Foods
$61.33 /

-1.9 (-3.00%)

SPCE Virgin Galactic
$16.82 /

+1.84 (+12.28%)

PEP PepsiCo
$131.53 /

+0.26 (+0.20%)

NVTA Invitae
$26.11 /

+7.5 (+40.30%)

LTHM Livent
$6.53 /

-1.135 (-14.82%)

AAPL Apple
$355.54 /

+5.99 (+1.71%)

TSN Tyson Foods
$61.33 /

-1.9 (-3.00%)

SPCE Virgin Galactic
$16.82 /

+1.84 (+12.28%)

PEP PepsiCo
$131.53 /

+0.26 (+0.20%)

LTHM Livent
$6.53 /

-1.135 (-14.82%)

LK Luckin Coffee
$3.19 /

-0.655 (-17.04%)

AAPL Apple
$355.54 /

+5.99 (+1.71%)

TSN Tyson Foods
$61.33 /

-1.9 (-3.00%)

SPCE Virgin Galactic
$16.82 /

+1.84 (+12.28%)

PEP PepsiCo
$131.53 /

+0.26 (+0.20%)

NVTA Invitae
$26.11 /

+7.5 (+40.30%)

LTHM Livent
$6.53 /

-1.135 (-14.82%)

LK Luckin Coffee
$3.19 /

-0.655 (-17.04%)

IDEX Ideanomics
$3.82 /

+1.6 (+72.07%)

AAPL Apple
$355.54 /

+5.99 (+1.71%)

TSN Tyson Foods
$61.33 /

-1.9 (-3.00%)

SPCE Virgin Galactic
$16.82 /

+1.84 (+12.28%)

PEP PepsiCo
$131.53 /

+0.26 (+0.20%)

NVTA Invitae
$26.11 /

+7.5 (+40.30%)

LK Luckin Coffee
$3.19 /

-0.655 (-17.04%)

IDEX Ideanomics
$3.82 /

+1.6 (+72.07%)

AAPL Apple
$355.54 /

+5.99 (+1.71%)

AAPL Apple
$355.54 /

+5.99 (+1.71%)

Hot Stocks
Invitae rises 39.3% » 12:00
06/22/20
06/22
12:00
06/22/20
12:00
NVTA

Invitae

$25.98 /

+7.37 (+39.60%)

Invitae is up 39.3%, or…

Invitae is up 39.3%, or $7.35 to $26.06.

ShowHide Related Items >><<
NVTA Invitae
$25.98 /

+7.37 (+39.60%)

NVTA Invitae
$25.98 /

+7.37 (+39.60%)

06/22/20 Piper Sandler
Invitae deal for ArcherDx presents little threat to Natera, says Piper Sandler
05/06/20 SVB Leerink
Invitae price target raised to $25 from $20 at SVB Leerink
04/02/20 Oppenheimer
Invitae price target lowered to $25 from $32 at Oppenheimer
02/20/20 Cowen
Invitae price target raised to $30 from $20 at Cowen
NVTA Invitae
$25.98 /

+7.37 (+39.60%)

NVTA Invitae
$25.98 /

+7.37 (+39.60%)

NVTA Invitae
$25.98 /

+7.37 (+39.60%)

Recommendations
Invitae deal for ArcherDx presents little threat to Natera, says Piper Sandler » 11:13
06/22/20
06/22
11:13
06/22/20
11:13
NTRA

Natera

$44.92 /

-1.53 (-3.29%)

, NVTA

Invitae

$27.04 /

+8.43 (+45.30%)

After Invitae (NVTA)…

After Invitae (NVTA) announced it will acquire ArcherDx - which is developing a kit-based personalized cancer recurrence monitoring test similar to Natera's (NTRA) Signatera offering - in a $1.4B deal, Piper Sandler analyst Steven Mah said he continues to see Signatera's service model as better suited for broader clinical use. The analyst, who also noted that Natera has a "premier partner in China" that better positions Signatera for global clinical trial use, continues to see Natera having a first-mover advantage and see little threat to his long-term Signatera thesis from Invitae's deal. Mah reiterates an Overweight rating and $63 price target on Natera shares.

ShowHide Related Items >><<
NVTA Invitae
$27.04 /

+8.43 (+45.30%)

NTRA Natera
$44.92 /

-1.53 (-3.29%)

NTRA Natera
$44.92 /

-1.53 (-3.29%)

06/09/20 Piper Sandler
Natera transferred with an Overweight at Piper Sandler
05/14/20 Piper Sandler
Natera price target raised to $56 from $49 at Piper Sandler
05/07/20 JPMorgan
Natera upgraded to Overweight on 'de-risked' story at JPMorgan
05/07/20 JPMorgan
Natera upgraded to Overweight from Neutral at JPMorgan
NVTA Invitae
$27.04 /

+8.43 (+45.30%)

05/06/20 SVB Leerink
Invitae price target raised to $25 from $20 at SVB Leerink
04/02/20 Oppenheimer
Invitae price target lowered to $25 from $32 at Oppenheimer
02/20/20 Cowen
Invitae price target raised to $30 from $20 at Cowen
01/28/20 Cowen
More flexible Medicare coverage for NGS a positive for Invitae, says Cowen
NVTA Invitae
$27.04 /

+8.43 (+45.30%)

NTRA Natera
$44.92 /

-1.53 (-3.29%)

NVTA Invitae
$27.04 /

+8.43 (+45.30%)

NVTA Invitae
$27.04 /

+8.43 (+45.30%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.